186 related articles for article (PubMed ID: 12897415)
21. The relationship between the enzyme activity, lipid peroxidation and red blood cells deformability in hemizygous and heterozygous glucose-6-phosphate dehydrogenase deficient individuals.
Gurbuz N; Yalcin O; Aksu TA; Baskurt OK
Clin Hemorheol Microcirc; 2004; 31(3):235-42. PubMed ID: 15322329
[TBL] [Abstract][Full Text] [Related]
22. Oxidative stress in elderly chronic renal failure patients: effects of renal replacement therapies on cell membrane fluidity.
Goi G; Massaccesi L; Baquero Herrera CJ; Musetti C; Ciurlino D; Cusi D; Bertoli S
J Nephrol; 2009; 22(5):630-6. PubMed ID: 19809996
[TBL] [Abstract][Full Text] [Related]
23. Erythrocyte glucose-6-phosphate dehydrogenase in chronic renal failure and after renal transplantation.
Milman N
Scand J Haematol; 1980 Apr; 24(4):307-14. PubMed ID: 6997987
[TBL] [Abstract][Full Text] [Related]
24. [The effect of hemodialysis, using acetate and bicarbonate, on erythrocyte deformability].
Novák Z; Búzás E; Salgó L; Gál G
Orv Hetil; 1991 Sep; 132(38):2083-6. PubMed ID: 1923480
[TBL] [Abstract][Full Text] [Related]
25. The effect of dialytic modalities on clinical outcomes in ESRD patients with familial Mediterranean fever.
Sahin S; Sahin GM; Ergin H; Kantarci G
Ren Fail; 2007; 29(3):315-9. PubMed ID: 17497446
[TBL] [Abstract][Full Text] [Related]
26. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
27. [Evaluation of the factor which has an influence on red blood cell deformability in patients with end-stage renal disease].
Tateishi K; Fujita J; Taminato T
Rinsho Byori; 2009 Oct; 57(10):965-70. PubMed ID: 19928493
[TBL] [Abstract][Full Text] [Related]
28. Mineral metabolism and cardiovascular morbidity and mortality risk: peritoneal dialysis patients compared with haemodialysis patients.
Noordzij M; Korevaar JC; Bos WJ; Boeschoten EW; Dekker FW; Bossuyt PM; Krediet RT
Nephrol Dial Transplant; 2006 Sep; 21(9):2513-20. PubMed ID: 16799173
[TBL] [Abstract][Full Text] [Related]
29. Enhanced methylglyoxal formation in the erythrocytes of hemodialyzed patients.
Karg E; Papp F; Tassi N; Janáky T; Wittmann G; Túri S
Metabolism; 2009 Jul; 58(7):976-82. PubMed ID: 19394056
[TBL] [Abstract][Full Text] [Related]
30. Serum ghrelin concentrations in patients with chronic renal failure undergoing dialysis.
Iglesias P; Díez JJ; Fernández-Reyes MJ; Codoceo R; Alvarez-Fidalgo P; Bajo MA; Aguilera A; Selgas R
Clin Endocrinol (Oxf); 2006 Jan; 64(1):68-73. PubMed ID: 16402931
[TBL] [Abstract][Full Text] [Related]
31. IGG and complement receptor expression on peripheral white blood cells in uraemic children.
Bouts AH; Krediet RT; Davin JC; Monnens LA; Nauta J; Schröder CH; van de Winkel JG; Out TA
Nephrol Dial Transplant; 2004 Sep; 19(9):2296-301. PubMed ID: 15266033
[TBL] [Abstract][Full Text] [Related]
32. Phagocytic activity of neutrophils from the peritoneal dialysate of patients with chronic renal failure treated by intermittent peritoneal dialysis.
Sułowicz W
Folia Haematol Int Mag Klin Morphol Blutforsch; 1990; 117(2):325-30. PubMed ID: 1697837
[TBL] [Abstract][Full Text] [Related]
33. Alterations of erythrocyte rheology and cellular susceptibility in end stage renal disease: Effects of peritoneal dialysis.
Ertan NZ; Bozfakioglu S; Ugurel E; Sinan M; Yalcin O
PLoS One; 2017; 12(2):e0171371. PubMed ID: 28158274
[TBL] [Abstract][Full Text] [Related]
34. Impairment of glutathione biosynthetic pathway in uraemia and dialysis.
Alhamdani MS
Nephrol Dial Transplant; 2005 Jan; 20(1):124-8. PubMed ID: 15632350
[TBL] [Abstract][Full Text] [Related]
35. Acute pancreatitis in patients on chronic peritoneal dialysis: an increased risk?
Quraishi ER; Goel S; Gupta M; Catanzaro A; Zasuwa G; Divine G
Am J Gastroenterol; 2005 Oct; 100(10):2288-93. PubMed ID: 16181382
[TBL] [Abstract][Full Text] [Related]
36. Comparison of infectious complications between incident hemodialysis and peritoneal dialysis patients.
Aslam N; Bernardini J; Fried L; Burr R; Piraino B
Clin J Am Soc Nephrol; 2006 Nov; 1(6):1226-33. PubMed ID: 17699352
[TBL] [Abstract][Full Text] [Related]
37. Electronegative LDL and lipid abnormalities in patients undergoing hemodialysis and peritoneal dialysis.
Lobo J; Santos F; Grosso D; Lima R; Barreira AL; Leite M; Mafra D; Abdalla DS
Nephron Clin Pract; 2008; 108(4):c298-304. PubMed ID: 18434752
[TBL] [Abstract][Full Text] [Related]
38. An analysis of the effectiveness and benefits of peritoneal dialysis and haemodialysis using Nigerian made PD fluids.
Arogundade FA; Ishola DA; Sanusi AA; Akinsola A
Afr J Med Med Sci; 2005 Sep; 34(3):227-33. PubMed ID: 16749353
[TBL] [Abstract][Full Text] [Related]
39. Plasma reduced homocysteine and other aminothiol concentrations in patients with CKD.
Sjöberg B; Anderstam B; Suliman M; Alvestrand A
Am J Kidney Dis; 2006 Jan; 47(1):60-71. PubMed ID: 16377386
[TBL] [Abstract][Full Text] [Related]
40. [Changes in the lipid content of erythrocytes in patients with chronic renal failure].
Witkowska J; Bober J; Chlubek D
Ann Acad Med Stetin; 2007; 53(2):46-51. PubMed ID: 18557376
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
